Healthy subjects volunteering for Phase I studies: influence of curiosity, exploratory tendencies and perceived self-efficacy.

OBJECTIVE To test the hypothesis that trait-curiosity and perceived self-efficacy influence the willingness of healthy subjects to volunteer for participation in Phase I studies. MATERIALS AND METHODS A group of healthy subjects who had never participated in clinical studies ("index group") were invited to participate in a Phase I study. They were assessed with regard to trait curiosity (Curiosity and Exploration Inventory; CEI-T) and perceived self-efficacy (Self-Efficacy Scale; SES) and subjects who accepted the invitation to participate were compared with those who refused and with a group of healthy subjects who had previously participated in clinical studies ("validation group"). RESULTS A significant positive correlation was found between the willingness to participate and the CEI-T total score (R=0.28; p<0.01), exploratory tendencies (R=0.34; p<0.001), SES total score (R=0.30, p<0.01), initiative and persistence (R=0.29, p<0.01), planning/goal setting (R=0.19, p<0.05) and social self-efficacy (R=0.29; p<0.01). The "index group" subjects who accepted the invitation to participate showed significantly greater CEI-T exploratory tendencies (Z=-3.334, p = 0.001, Mann-Whitney test) and total scores (Z=-2.703, p<0.01) and greater SES total score (Z=-3.131, p<0.01), initiative and persistence (Z=-3.065, p<0.01), planning/goal setting (Z=-2.173, p<0.05) and social self-efficacy (Z=-2.954, p<0.01) than subjects who refused. No differences were found between the subjects in the "index group" who accepted the invitation and subjects in the "validation group". Using a logistic regression model, both CEI-T exploratory tendencies and SES initiative/persistence were significant predictors of participation. CONCLUSION Subjects higher in curiosity/exploration and in perceived initiative/persistence are more willing to volunteer for Phase I studies. The impact of these self-selection biases on Phase I study results is unknown but deserves further evaluation.

[1]  Patrício Soares-da-Silva,et al.  Why healthy subjects volunteer for phase I studies and how they perceive their participation? , 2007, European Journal of Clinical Pharmacology.

[2]  Todd B. Kashdan,et al.  Curiosity and pathways to well-being and meaning in life: Traits, states, and everyday behaviors , 2007 .

[3]  P. Silvia.  Exploring the Psychology of Interest , 2006 .

[4]  F. Fincham,et al.  Curiosity and Exploration: Facilitating Positive Subjective Experiences and Personal Growth Opportunities , 2004, Journal of personality assessment.

[5]  M. Seligman,et al.  Character Strengths and Virtues: A Handbook and Classification , 2004 .

[6]  T. Kashdan.  Social Anxiety Dimensions, Neuroticism, and the Contours of Positive Psychological Functioning , 2002, Cognitive Therapy and Research.

[7]  S. Bartholomae,et al.  The Recruitment of Normal Healthy Volunteers: A Review of The Literature on the Use of Financial Incentives , 2002, Journal of clinical pharmacology.

[8]  Meyer Fp.  Psycho- and immunopharmacological factors relevant to selection of volunteers in clinical studies. , 2001 .

[9]  A. Viens.  Socio-Economic Status and Inducement to Participate , 2001 .

[10]  U. Tröger,et al.  Reliability of Symptom Reports by Healthy Volunteers Treated with Placebo over Several Time Periods , 2000, Arzneimittelforschung.

[11]  A. Bandura.  Self-Efficacy: The Exercise of Control , 1997, Journal of Cognitive Psychotherapy.

[12]  L. Krames,et al.  Personality Correlates of Depression and Health Symptoms: A Test of a Self-Regulation Model , 1996 .

[13]  M. Farré,et al.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials. , 1995, British journal of clinical pharmacology.

[14]  M. Drici,et al.  Influence of the behaviour pattern on the nocebo response of healthy volunteers. , 1995, British journal of clinical pharmacology.

[15]  P. Mclaren,et al.  The personality structure of 'normal' volunteers. , 1993, British journal of clinical pharmacology.

[16]  S. Woodruff,et al.  Task, Domain, and General Efficacy: A Reexamination of the Self-Efficacy Scale , 1993 .

[17]  E. Arch.  Affective Control Efficacy as a Factor in Willingness to Participate in a Public Performance Situation , 1992 .

[18]  R. Vrhovac,et al.  Drug trials on healthy volunteers in Yugoslavia. , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[19]  R. W. Rogers,et al.  The Self-Efficacy Scale: Construction and Validation , 1982 .

[20]  L. Newton.  Inducement, due and otherwise. , 1982, IRB.

[21]  Kenneth A. Bollen,et al.  Issues in the Comparative Measurement of Political Democracy , 1980 .

[22]  L Lasagna,et al.  Free‐living volunteer's motivations and attitudes toward pharmacologic studies in man , 1977, Clinical pharmacology and therapeutics.

[23]  A. Bandura.  Self-efficacy: toward a unifying theory of behavioral change. , 1977, Psychological review.

[24]  J. Baños,et al.  Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials , 2006, European Journal of Clinical Pharmacology.

[25]  S. Bartholomae,et al.  Personality profiles of normal healthy research volunteers: a potential concern for clinical drug trial investigators? , 2005, Medical hypotheses.

[26]  J. Meulenbelt,et al.  Motives and perception of healthy volunteers who participate in experiments , 2004, European Journal of Clinical Pharmacology.

[27]  R. Haschke,et al.  The healthy volunteer in clinical pharmacology: personality and motivation , 2004, European Journal of Clinical Pharmacology.

[28]  Stephen Joseph,et al.  Positive psychology in practice , 2004 .

[29]  F. Meyer.  Psycho- and immunopharmacological factors relevant to selection of volunteers in clinical studies. , 2001, International journal of clinical pharmacology and therapeutics.

[30]  J. E. Maddux.  Self-efficacy, adaptation, and adjustment: Theory, research, and application. , 1995 .

[31]  J. Ribeiro.  Adaptação de uma escala de avaliação da auto-eficácia geral , 1995 .

[32]  Terri Gullickson,et al.  Encyclopedia of human behavior , 1995 .

[33]  A. Bandura.  Self-efficacy. I: V. S. Ramachandran (red.), Encyclopedia of human behavior (vol. s. ). New York: Academic Press. , 1994 .

[34]  A. Jennekens‐Schinkel,et al.  Self-selection for personality variables among healthy volunteers. , 1992, British journal of clinical pharmacology.

[35]  Joseph R. Ferrari,et al.  Academic procrastination: Personality correlates with Myers-Briggs types, self-efficacy, and academic locus of control. , 1992 .

[36]  M. Farré,et al.  Personality of healthy volunteers participating in phase I clinical trials , 1989 .